Transbrachial Access for Interventions in Patients With Peripheral Arterial Occlusive Disease

NCT ID: NCT05892367

Last Updated: 2023-06-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

95 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-10

Study Completion Date

2020-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is an evaluation, whether an immobilization of the upper extremity by means of a positioning splint can help to reduce the incidence of local complications after transbrachial puncture for peripheral arterial interventions, or not.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Increasing numbers of peripheral arterial interventions are performed via transbrachial access leading to a higher number of local complications at the puncture site. Patients are demonstrating complications, such as hematoma, false aneurysm, secondary hemorrhage and arterial stenosis or occlusion.

Due to not standardized post-interventional procedure regarding to immobilization a higher risk for local puncture site complication can occur. Usually, a compression bandage its applied to the brachial puncture site. Within this randomized study, patients randomized to the study group will receive an additional splint for 24 hours to ensure an immobilization of the affected arm.

Following the removal of the compression dressing, and the splint in the study group, a duplex ultrasound its performed in order to detect local alterations and pathologies of the brachial artery.

This examination is repeated for each patient in the course of an outpatient control six weeks post-interventionally. Pathologies are documented and treated if necessary.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Complication of Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Control group: compression bandage Study group: compression bandage and positioning splint
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

Application of a compression bandage following transbrachial puncture for 24 hours

Group Type OTHER

Transbrachial Access for Interventions

Intervention Type OTHER

Adding a positioning splint in addition to compression bandage after intervention in order to guarantee immobilization of puncture site

Study group

Application of a compression bandage and a positioning splint following transbrachial puncture for 24 hours

Group Type ACTIVE_COMPARATOR

Transbrachial Access for Interventions

Intervention Type OTHER

Adding a positioning splint in addition to compression bandage after intervention in order to guarantee immobilization of puncture site

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transbrachial Access for Interventions

Adding a positioning splint in addition to compression bandage after intervention in order to guarantee immobilization of puncture site

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female and male patients suffering from peripheral arterial occlusive disease with indicated interventions via an transbrachial access (puncture of the left or right brachial artery)
* age \> 18 years
* approval to participate

Exclusion Criteria

* unability or refusal to participate
* dialysis patients/AV-fistula interventions
* usage of closure devices
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wilhelminenspital Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Edda Skrinjar, M.D.

M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Afshin Assadian, Prim. PD Dr.

Role: PRINCIPAL_INVESTIGATOR

Vascular and Endovascular Surgery, Klinik Ottakring

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Vascular and Endovascular Surgery

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TBA 1.2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.